Assistant Professor, Medicine, University of Florida College of Medicine
Hematology
Dr. Jack W. Hsu, MD
|
|
Give Review
Jack works in the field of Hematology. He attended UMDNJ-Robert Wood Johnson Medical School. Jack is a published doctor. He published 31 publications, including: 'Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen:...' Jack W. Hsu, MD is registered with Medicare and accepts Medicare payments.
Publications
- Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen:...
- Increasing incidence of Chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.
- Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor Cells from unrelated donors, a Center for Inter...
- Alternative donors extend transplantation for patients with Lymphoma who lack an HLA matched donor.
- Long-term Survival and Late Effects among 1-year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Synd...
- Hematopoietic Stem-Cell Transplantation for Advanced Systemic Mastocytosis.
- Second solid cancers after allogeneic hematopoietic Cell transplantation using reduced intensity conditioning.
- Tacrolimus/sirolimus versus tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic hematopoietic Cell transplantation.
- Outcomes of Human Leukocyte Antigen-Matched Sibling Donor Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia: Myeloablative Versus Reduced-Intensity Co...
- Avascular necrosis of bone after allogeneic hematopoietic Cell transplantation in children and adolescents.
- Elevated incidence of Chronic myeloid leukaemia in immunosuppressed solid organ transplant recipients.
- Outcomes of hematopoietic cell transplantation for diffuse large B cell Lymphoma transformed from follicular Lymphoma.
- Allotransplantation for patients age 40 years and greater with non-Hodgkin Lymphoma (NHL): encouraging progression-free survival.
- ALK1 as a Novel Therapeutic Target for CD30+ T-Anaplastic Large Cell Lymphoma.
- Does Total Body Irradiation Conditioning Improve Outcomes of Myeloablative Human Leukocyte Antigen-Identical Sibling Transplantations for Chronic Lymphocytic Leukemia?
- Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma.
- Impact of Pretransplantation Conditioning Regimens on Outcomes of Allogeneic Transplantation for Chemotherapy-Unresponsive Diffuse Large B Cell Lymphoma and Grade III ...
- The role of monoclonal antibodies in the treatment of Lymphomas.
- Autologous and allogeneic transplantation for burkitt Lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transpl...
- Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell Lymphoma: a cohort analysis from the center for international blood and marrow ...
- Quality of life, social challenges, and psychosocial support for long-term survivors after allogeneic hematopoietic stem-Cell transplantation.
- Alternate donor hematopoietic cell transplantation (HCT) in non-Hodgkin Lymphoma using lower intensity conditioning: a report from the CIBMTR.
- Comparison of short-term response and long-term outcomes after initial systemic treatment of Chronic graft-versus-host disease.
- Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin Lymphoma relapsing after an autologous stem cell transplant.
- Reconstitution of T Cell subset repertoire diversity following multiple antigen-mismatched bone marrow transplantation.
- Myelodysplastic subclones in chronic myeloid Leukemia: implications for imatinib mesylate therapy.
- Uric Acid and the Prediction Models of Tumor Lysis Syndrome in AML.
- Tandem Autologous Stem Cell Transplantation for Multiple Myeloma Patients Based on Response to Their First Transplant-A Prospective Phase II Study.
- Advances in the management of viral infections.
- Parvovirus b19-associated pure red cell aplasia in Chronic graft-versus-host disease.
Schools
Thomas Jefferson University
UMDNJ R W Johnson Med School
Procedures Preformed
- Bone Marrow Transplant
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anemia
- Burkitt's Lymphoma
- Chronic Myeloid Leukemia (CML)
- View All
Doctors Specialties
- Hematology
Accepted Insurances
Education
-
UMDNJ-Robert Wood Johnson Medical School -
Jefferson Medical College
Hospital
-
UF Health Shands Hospital
Drug Facts
| NPI NUMBER | 1902867575 | |
| NPPES Provider LastName | HSU | |
| NPPES Provider FirstName | JACK | |
| NPPES Provider ZIPCode | 326103003 | |
| NPPES Provider State | FL | |
| Specialty Description | Hematology | |
| Total Claim Count | 620.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 50.0 | |
| Percent Opioid Claims | 8.06 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1902867575 |
| Last Name Of The Provider | HSU |
| First Name Of The Provider | JACK |
| View All |
Similar Doctors
|
|
Dr. Rufino J. Garcia, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard Lottenberg, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jennifer L. Ricks, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William L. Clapp III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas J. George Jr., MD |
|
|
Dr. Allison R. Carilli, MD |
|
|
Dr. Ying Z. Li, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ravneet Bajwa, MD |
|
|
Dr. Jessica M. Linder, MD |
|
|
Dr. Napoleon Santos, DO |